# Expanding the Therapeutic Pipeline for Treating and Preventing Alzheimer's Disease and Related Dementias: Preclinical Validation and Drug Discovery for Novel Candidate Targets (U01 Clinical Trial Not Allowed)

Federal grant opportunity, via Kontrakk.

- **Agency:** National Institutes of Health
- **Opportunity number:** PAR-26-132
- **Status:** forecasted
- **Opens:** March 4, 2026
- **CFDA:** 93.866
- **View on Kontrakk:** https://kontrakk.com/grants/361411

## Description

No description provided.
